BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23690366)

  • 1. Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.
    Wahezi DM; Ilowite NT; Wu XX; Pelkmans L; Laat B; Schanberg LE; Rand JH;
    Lupus; 2013 Jun; 22(7):702-11. PubMed ID: 23690366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases.
    Wahezi DM; Ilowite NT; Rajpathak S; Rand JH
    J Rheumatol; 2012 Feb; 39(2):382-8. PubMed ID: 22174207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.
    Wolgast LR; Arslan AA; Wu XX; Beyda JN; Pengo V; Rand JH
    J Thromb Haemost; 2017 Jul; 15(7):1412-1421. PubMed ID: 28393472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.
    Demir S; Li J; Magder LS; Petri M
    Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
    Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
    Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
    Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y
    Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.
    de Laat B; Wu XX; van Lummel M; Derksen RH; de Groot PG; Rand JH
    Blood; 2007 Feb; 109(4):1490-4. PubMed ID: 17053060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
    Bećarević M; Sarić M; Stojanovich L; Mirković D; Dopsaj V; Ignjatović S
    Clin Rheumatol; 2018 Dec; 37(12):3359-3364. PubMed ID: 29948348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
    de Laat B; Mertens K; de Groot PG
    Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
    Pericleous C; D'Souza A; McDonnell T; Ripoll VM; Leach O; Isenberg D; Giles I; Rahman A
    Rheumatology (Oxford); 2020 Jan; 59(1):146-152. PubMed ID: 31257438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
    Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
    Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered β
    Mobarrez F; Gunnarsson I; Svenungsson E
    J Thromb Haemost; 2017 Sep; 15(9):1799-1806. PubMed ID: 28667788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.
    Ferreira TG; Delhommeau F; Johanet C; Gerotziafas G; Bornes M; Cohen J; Kayem G; Fain O; Planche V; Mékinian A
    Clin Rheumatol; 2020 Apr; 39(4):1167-1171. PubMed ID: 31925628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Antiphospholipid syndrome using Annexin A5 competition assay in patients with SLE.
    Avriel A; Fleischer S; Friger M; Shovman O; Neuman G; Shoenfeld Y; Abu-Shakra M
    Clin Rheumatol; 2016 Dec; 35(12):2933-2938. PubMed ID: 27704312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.